Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,856 papers from all fields of science
Search
Sign In
Create Free Account
Dermatitis acneiform
Known as:
ACNEIFORM DERMATITIS
, Rash acneiform
Cutaneous eruptions resembling acne, characterized by the presence of papulonodules, pustules, comedones, or cysts in the face, trunk, and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (2)
Acne
Acne Vulgaris
Integumentary system
Skin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Folliculotropic Mycosis Fungoides in an Adolescent: A Rare Case
M. D. Mantri
,
Mona P Khadke
,
Dandale L Ameet
,
Dhurat S Rachita
Indian Journal of Dermatology
2016
Corpus ID: 41087595
Folliculotropic mycosis fungoides (FMF) is an uncommon and aggressive form of mycoses fungoides with preferential involvement of…
Expand
2015
2015
Occluded Cigarette Smoke Exposure Causing Localized Chloracne-Like Comedones
Andrew T. Patterson
,
Frances T. Tian
,
D. Elston
,
B. Kaffenberger
Dermatology
2015
Corpus ID: 6253478
Many environmental acne disorders, including chloracne and oil acne, were previously thought to occur predominantly in…
Expand
2015
2015
Acneiform primary cutaneous CD4‐positive small/medium pleomorphic T‐cell lymphoma with prominent necrosis
Lei Wang
,
Gang Wang
,
T. Gao
Journal of cutaneous pathology
2015
Corpus ID: 1556860
Primary cutaneous CD4‐positive small/medium pleomorphic T‐cell lymphoma (SMPTCL) is an indolent form of cutaneous lymphoma that…
Expand
2014
2014
A comedonal acneiform eruption following dovitinib therapy
T. Gracia-Cazaña
,
I. Pastushenko
,
M. Concellón
,
M. P. Grasa-Jordán
Clincal and Experimental Dermatology
2014
Corpus ID: 6226161
M. Lynch, A.-M. Tobin, T. Ahern, D. O’Shea, and B. Kirby Dermatology, St Vincent’s University Hospital, Elm Park, Dublin 4…
Expand
2013
2013
Abstract LB-147: Combination of the MEK inhibitor, pimasertib (MSC1936369B), and the PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation…
J. Infante
,
Leena Gandi
,
+9 authors
R. Heist
2013
Corpus ID: 72739156
Background: The PI3K/mTOR and MAPK signaling pathways are frequently aberrated in tumors and interact to promote growth. This…
Expand
2012
2012
Dacomitinib (PF-00299804), An Irreversible Pan-Her Tyrosine Kinase Inhibitor (TKI), For First-Line Treatment of EGFR-Mutant or Her2-Mutant or -Amplified Lung Cancers
M. Kris
,
Tony S K Mok
,
+7 authors
P. Jänne
2012
Corpus ID: 220740894
2011
2011
Phase Ib study of ficlatuzumab (formerly AV-299), an anti-hepatocyte growth factor (HGF) monoclonal antibody (MAb) in combination with gefitinib (G) in Asian patients (pts) with NSCLC.
E. Tan
,
K. Park
,
+13 authors
W. Slichenmyer
Journal of Clinical Oncology
2011
Corpus ID: 19279525
7571 Background: Ficlatuzumab is a humanized anti-HGF IgG1 MAb that inhibits activation of the c-Met receptor by neutralizing its…
Expand
Review
2006
Review
2006
Rosacea: clinical presentation and pathophysiology.
S. Diamantis
,
H. Waldorf
Journal of Drugs in Dermatology
2006
Corpus ID: 42955276
Acne rosacea is one of the most common diagnoses seen in the clinical dermatologic practice. The classic presentation of rosacea…
Expand
2005
2005
Chronic Superficial Pyoderma of the Face: An Unusual Male Case of Rosacea Fulminans
R. Mori
,
S. Matsushima
,
T. Honda
,
Y. Horiguchi
,
S. Imamura
Journal of dermatology (Print)
2005
Corpus ID: 13056356
A 62‐year‐old Japanese male developed acneiform papules on the face in November of 2002. The eruptions progressed to exudative…
Expand
Review
1970
Review
1970
Personal susceptibility to pitch
G. Hodgson
,
H. J. Whiteley
1970
Corpus ID: 72261460
Hodgson, G. A., and Whiteley, H. J. (1970).Brit. J. industr. Med.,27, 160-166. Personal susceptibility to pitch. During the years…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE